Status:

RECRUITING

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

Lead Sponsor:

Shanghai General Hospital, China

Collaborating Sponsors:

Wuxi People's Hospital Affiliated to Nanjing Medical University

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions:

Pneumonia

Next-generation Sequencing

Eligibility:

All Genders

Brief Summary

Monitoring of antimicrobial resistance (AMR) based on metagenomics analyses in pneumonia patients is critical for optimizing clinical diagnosis and treatment and improving clinical prognosis. This stu...

Detailed Description

This is a historical prospective obsevational study. Patients diagnosed with severe and mild pneumonia are recruited continously from four hospitals (Shanghai General Hospital, Wuxi People's Hospital ...

Eligibility Criteria

Inclusion

  • Patients clinically diagnosed as severe pneumonia and mild pneumonia are diagnosed according to the Guidelines for the diagnosis and Treatment of community-acquired pneumonia in Adults (2019 edition) formulated by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA), who meet 1 of the following major criteria or ≥3 minor criteria can be diagnosed. The diagnostic criteria for severe and mild pneumonia in children were adopted by the British Thoracic Society (BTS) in 2011.
  • Clinical examination was performed, and there was biospecimen (nasopharyngeal swab, oropharyngeal swab, bronchoalveolar lavage fluid, sputum, blood, hydrothorax, lung tissue) remaining in the clinical microbiological examination.

Exclusion

  • Patients whose biological samples may be contaminated;
  • Patients with alveolar lavage fluid or hydrothorax volume less than 200μl.

Key Trial Info

Start Date :

August 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 30 2026

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT06566898

Start Date

August 1 2024

End Date

May 30 2026

Last Update

August 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mei Kang

Shanghai, Shanghai Municipality, China, 200080